The question is, is this a good trading stock or a long term growth stock. I believe it is the latter. Software development is always tricky and getting anyone to part with hard earned cast in the retail market is even trickier. I had a friend die of cancer after Amazon let him go. He save them $5 million annually and got canned. That is retail, probably the most ruthless business on the Planet (i.e. Walmart). If PCYG doesn't really save their users a boatload of money, trust me, Target and many others would have fired them long ago. If the savings are only one time, they are still fired. But the trick of this game is recurring revenue, always my favorite and saving the customers money on a recurring basis.
The real lack of transparency is the lack of revenue growth. Like the famous cigarette line (the first one is always free); Randy needs to be more forthcoming on when these legacy businesses will produce significant revenue growth. When will they start producing as the chart says. That lack of transparency makes this a poor trading stock. It is always news related, not revenue related.
I still think it is a long term growth stock. Between the FDA, Walmart's supply chain mojo and the increase in chain restaurants, I see a huge potential marketplace for PCYGs products. I also believe with Randy's track record, he is well placed to accomplish those goals. I am looking forward to $50m in revenue in 3 years.